Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 19, 2014

Valerie Palmieri, James LaFrance

Vermillion has named Valerie Palmieri president and CEO effective Jan. 1. Current CEO James LaFrance will continue to serve as chairman of the company's board.

Palmieri is currently Vermillion's COO. Prior to joining the company in October, she was president of Momentum Consulting and served as a strategic advisor to the company. Before that she was national vice president of anatomic pathology operations at Laboratory Corporation of America.


Kathy Ordoñez

Pacific Biosciences has appointed Kathy Ordoñez to the board of directors. For the last 30 years, she has held leadership positions in the life sciences and diagnostics industries, including as senior vice president of Quest Diagnostics, CEO of Celera, founder of Celera Diagnostics, and president and CEO of Roche Molecular Systems.


Patrick Terry

Claritas Genomics has appointed Patrick Terry as chief commercial officer. As CCO, Terry will expand Claritas' reach to pediatric hospitals and patients. Terry is chairman of Gray Group Ventures and was a founder of Genomic Health. Previously, he and his wife, Sharon Terry, founded PXE International to accelerate research into the rare genetic disease pseudoxanthoma elasticum. He has co-founded and advised multiple life science ventures, including two applied genetics companies. He was a principal advisor with Scientia Advisors and co-founded the Personalized Medicine Coalition, the European Personalized Medicine Association, and the International Genetic Alliance. 


For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.